PRESS RELEASE published on 05/21/2026 at 22:00, 4 months 13 days ago Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference à New York City son traitement oral pour la stéatohépatite. Détails de la présentation le 3 juin 2026 Inventiva Lanifibranor Stéatohépatite 2026 Jefferies Global Healthcare Conference Traitement Oral
BRIEF published on 05/13/2026 at 08:35, 4 months 21 days ago Inventiva présente ses recherches sur le lanifibranor au EASL Congress 2026 Biopharmaceutique Inventiva MASH Lanifibranor EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 4 months 21 days ago Inventiva présentera des résumés au congrès EASL 2026 Recherche Biopharmaceutique Inventive Lanifibranor Traitement MASH Congrès EASL 2026
BRIEF published on 05/13/2026 at 08:35, 4 months 21 days ago Inventiva to Present Abstracts at EASL Congress 2026 Biopharmaceutical Research Inventiva Lanifibranor MASH Treatment EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 4 months 21 days ago Inventiva presents its research on lanifibranor at the EASL Congress 2026 Biopharmaceutical Inventiva MASH Lanifibranor EASL Congress 2026
PRESS RELEASE published on 05/13/2026 at 08:30, 4 months 21 days ago Inventiva to Present Abstracts at the EASL Congress 2026 Inventiva to present two abstracts at EASL Congress 2026 highlighting Lanifibranor's impact on MASH treatment. Lanifibranor, a pan-PPAR agonist, shows promising results in clinical trials Clinical Trials Inventiva Lanifibranor MASH Treatment EASL Congress 2026
PRESS RELEASE published on 05/13/2026 at 08:30, 4 months 21 days ago Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026 Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026. Découvrez les détails des présentations et la présence de la société au congrès Biopharmaceutique Inventiva MASH Lanifibranor EASL Congress 2026
BRIEF published on 04/22/2026 at 22:05, 5 months 11 days ago Inventiva renforce sa direction pour la phase 3 du lanifibranor Nomination Biopharmaceutique Direction Phase 3 Lanifibranor
BRIEF published on 04/22/2026 at 22:05, 5 months 11 days ago Inventiva Bolsters Executive Team as It Nears Key Phase 3 Data Milestone Phase 3 Trial Lanifibranor Leadership Expansion MASH Treatment Inventiva Biopharmaceutical
BRIEF published on 04/22/2026 at 22:05, 5 months 11 days ago Inventiva renforce son équipe de direction à l'approche d'une étape clé de la phase 3. Essai De Phase 3 Lanifibranor Développement Du Leadership Traitement MASH Inventiva Biopharmaceutique
Published on 10/02/2026 at 13:50, 1 day 16 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 17 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 17 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 37 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 1 hour 27 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 14 hours 57 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 6 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 10 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 1 day 12 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 12 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 13 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 13 hours ago Aéroports de Paris SA - Calendrier financier 2027
